Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-26T16:36:06.846Z Has data issue: false hasContentIssue false

LHX6 promoter hypermethylation in oncological pediatric patients conceived by IVF

Published online by Cambridge University Press:  26 September 2022

Gustavo Dib Dangoni
Affiliation:
Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, SP, Brazil
Anne Caroline Barbosa Teixeira
Affiliation:
Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, SP, Brazil
Carolina Sgarioni Camargo Vince
Affiliation:
Institute for the Treatment of Childhood Cancer (ITACI) – Hospital das Clínicas, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil
Estela Maria Novak
Affiliation:
Institute for the Treatment of Childhood Cancer (ITACI) – Hospital das Clínicas, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil
Thamiris Magalhães Gimenez
Affiliation:
Institute for the Treatment of Childhood Cancer (ITACI) – Hospital das Clínicas, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil
Mariana Maschietto
Affiliation:
Research Center, Boldrini Children’s Hospital, Campinas, SP, Brazil
Vicente Odone Filho
Affiliation:
Institute for the Treatment of Childhood Cancer (ITACI) – Hospital das Clínicas, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil
Ana Cristina Victorino Krepischi*
Affiliation:
Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, SP, Brazil
*
Address for correspondence: Ana Cristina Victorino Krepischi. Institute of Biosciences - University of São Paulo - Rua do Matão 277, 05508-090, São Paulo, SP, Brazil. Email: ana.krepischi@ib.usp.br

Abstract

The multifactorial etiology of pediatric cancer is poorly understood. Environmental factors occurring during embryogenesis can disrupt epigenetic signaling, resulting in several diseases after birth, including cancer. Associations between assisted reproductive technologies (ART), such as in vitro fertilization (IVF), and birth defects, imprinting disorders and other perinatal adverse events have been reported. IVF can result in methylation changes in the offspring, and a link with pediatric cancer has been suggested. In this study, we investigated the peripheral blood methylomes of 11 patients conceived by IVF who developed cancer in childhood. Methylation data of patients and paired sex/aged controls were obtained using the Infinium MethylationEPIC Kit (Illumina). We identified 25 differentially methylated regions (DMRs), 17 of them hypermethylated, and 8 hypomethylated in patients. The most significant DMR was a hypermethylated genomic segment located in the promoter region of LHX6, a transcription factor involved in the forebrain development and interneuron migration during embryogenesis. An additional control group was included to verify the LHX6 methylation status in children with similar cancers who were not conceived by ART. The higher LHX6 methylation levels in IVF patients compared to both control groups (healthy children and children conceived naturally who developed similar pediatric cancers), suggested that hypermethylation at the LHX6 promoter could be due to the IVF process and not secondary to the cancer itself. Further studies are required to evaluate this association and the potential role of LHX6 promoter hypermethylation for tumorigenesis.

Type
Brief Reports
Copyright
© The Author(s), 2022. Published by Cambridge University Press in association with International Society for Developmental Origins of Health and Disease

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Vicente Odone Filho and Ana Cristina Victorino Krepischi equally contribution last authors.

References

Qin, J, Liu, X, Sheng, X, Wang, H, Gao, S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016; 105(1), 7385.CrossRefGoogle ScholarPubMed
Lv, H, Diao, F, Du, J, et al. Assisted reproductive technology and birth defects in a Chinese birth cohort study. Lancet Reg Heal - West Pacific. 2021; 7(2), 100090.CrossRefGoogle Scholar
Cortessis, VK, Azadian, M, Buxbaum, J, et al. Comprehensive meta-analysis reveals association between multiple imprinting disorders and conception by assisted reproductive technology. J Assist Reprod Genet. 2018; 35(6), 943952.CrossRefGoogle ScholarPubMed
Henningsen, AA, Gissler, M, Rasmussen, S, et al. Imprinting disorders in children born after ART: a Nordic study from the CoNARTaS group. Hum Reprod. 2020; 35(5), 11781184.CrossRefGoogle ScholarPubMed
Gardner, DK, Kelley, RL. Impact of the IVF laboratory environment on human preimplantation embryo phenotype. J Dev Orig Health Dis. 2017; 8(4), 418435.CrossRefGoogle ScholarPubMed
Feuer, SK, Rinaudo, PF. Physiological, metabolic and transcriptional postnatal phenotypes of in vitro fertilization (IVF) in the mouse. J Dev Orig Health Dis. 2017; 8(4), 403410.CrossRefGoogle ScholarPubMed
Raimondi, S, Pedotti, P, Taioli, E. Meta-analysis of cancer incidence in children born after assisted reproductive technologies. Br J Cancer. 2005; 93(9), 10531056.CrossRefGoogle ScholarPubMed
Hargreave, M, Jensen, A, Toender, A, Andersen, KK, Kjaer, SK. Fertility treatment and childhood cancer risk: a systematic meta-analysis. Fertil Steril. 2013; 100(1), 150161.CrossRefGoogle Scholar
Wang, T, Chen, L, Yang, T, et al. Cancer risk among children conceived by fertility treatment. Int J Cancer. 2019; 144(12), 30013013.CrossRefGoogle ScholarPubMed
Gilboa, D, Koren, G, Barer, Y, et al. Assisted reproductive technology and the risk of pediatric cancer: a population based study and a systematic review and meta analysis. Cancer Epidemiol. 2019; 63(September (9)), 101613.CrossRefGoogle Scholar
Edgar, R, Domrachev, M, Lash, AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002; 30(1), 207210.CrossRefGoogle ScholarPubMed
Tian, Y, Morris, TJ, Webster, AP, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017; 33(24), 39823984.CrossRefGoogle ScholarPubMed
R Core Team. A Language and Environment for Statistical Computing, 2021.Google Scholar
Aryee, MJ, Jaffe, AE, Corrada-Bravo, H, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014; 30(10), 13631369.CrossRefGoogle ScholarPubMed
Fortin, JP, Triche, TJ, Hansen, KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017; 33(4), 558560.Google ScholarPubMed
Teschendorff, AE, Marabita, F, Lechner, M, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013; 29(2), 189196.CrossRefGoogle ScholarPubMed
Dedeurwaerder, S, Defrance, M, Calonne, E, Denis, H, Sotiriou, C, Fuks, F. Evaluation of the Infinium Methylation 450K technology. Epigenomics. 2011; 3(6), 771784.CrossRefGoogle ScholarPubMed
Maksimovic, J, Gordon, L, Oshlack, A. SWAN: subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol. 2012; 13(6), R44.CrossRefGoogle ScholarPubMed
Teschendorff, AE, Menon, U, Gentry-Maharaj, A, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. In PLoS One. vol. 4, Aramayo, R), 2009; pp. e8274.Google Scholar
Johnson, WE, Li, C, Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007; 8(1), 118127.CrossRefGoogle ScholarPubMed
Leek, JT, Johnson, WE, Parker, HS, et al. sva: Surrogate Variable Analysis. R package version 3.40.0. Published online 2017.Google Scholar
Houseman, EA, Accomando, WP, Koestler, DC, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinf. 2012; 13(1), 86.CrossRefGoogle ScholarPubMed
Smyth, GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3(1), 125.CrossRefGoogle ScholarPubMed
Wettenhall, JM, Smyth, GK. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 2004; 20(18), 37053706.CrossRefGoogle ScholarPubMed
Jaffe, AE, Murakami, P, Lee, H, et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol. 2012; 41(1), 200209.CrossRefGoogle ScholarPubMed
Benjamini, Y, Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995; 57(1), 289300.Google Scholar
Plotly Technologies Inc. Collaborative Data Science, 2015,Google Scholar
Latino-Martel, P, Chan, DSM, Druesne-Pecollo, N, Barrandon, E, Hercberg, S, Norat, T. Maternal alcohol consumption during pregnancy and risk of childhood leukemia: systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010; 19(5), 12381260.CrossRefGoogle ScholarPubMed
Mansell, G, Gorrie-Stone, TJ, Bao, Y, et al. Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array. BMC Genomics. 2019; 20(1), 115.CrossRefGoogle ScholarPubMed
Moore, LE, Pfeiffer, RM, Poscablo, C, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol. 2008; 9(4), 359366.CrossRefGoogle ScholarPubMed
Woo, HD, Kim, J. Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. In PLoS One. vol. 7, Christensen, BC), 2012; pp. e34615.Google Scholar
Caramaschi, D, Jungius, J, Page, CM, et al. Association of medically assisted reproduction with offspring cord blood DNA methylation across cohorts. Hum Reprod. 2021; 36(8), 24032413.CrossRefGoogle ScholarPubMed
Wozniak, MB, Le Calvez-Kelm, F, Abedi-Ardekani, B, et al. Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States. In PLoS One. vol. 8, Hoque, MO), 2013; pp. e57886.Google Scholar
Gross, AM, Jaeger, PA, Kreisberg, JF, et al. Methylome-wide analysis of chronic HIV infection reveals five-year increase in biological age and epigenetic targeting of HLA. Mol Cell. 2016; 62(2), 157168.CrossRefGoogle ScholarPubMed
Xu, C-J, Bonder, MJ, Söderhäll, C, et al. The emerging landscape of dynamic DNA methylation in early childhood. BMC Genomics. 2017; 18(1), 25.CrossRefGoogle ScholarPubMed
Liodis, P, Denaxa, M, Grigoriou, M, Akufo-Addo, C, Yanagawa, Y, Pachnis, V. Lhx6 activity is required for the normal migration and specification of cortical interneuron subtypes. J Neurosci. 2007; 27(12), 30783089.CrossRefGoogle ScholarPubMed
Grigoriou, M, Tucker, AS, Sharpe, PT, Pachnis, V. Expression and regulation of Lhx6 and Lhx7, a novel subfamily of LIM homeodomain encoding genes, suggests a role in mammalian head development. Development. 1998; 125(11), 20632074.CrossRefGoogle ScholarPubMed
Yuan, F, Fang, KH, Hong, Y, et al. LHX6 is essential for the migration of human pluripotent stem cell-derived GABAergic interneurons. Protein Cell. 2020; 11(4), 286291.CrossRefGoogle ScholarPubMed
Yan, L, Cai, K, Sun, K, Gui, J, Liang, J. MiR-1290 promotes proliferation, migration, and invasion of glioma cells by targeting LHX6. J Cell Physiol. 2018; 233(10), 66216629.CrossRefGoogle ScholarPubMed
Abudurexiti, Y, Gu, Z, Chakma, K, et al. Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer. Biochem Biophys Res Commun. 2020; 526(3), 626632.CrossRefGoogle ScholarPubMed
Estécio, MRH, Youssef, EM, Rahal, P, et al. LHX6 is a sensitive methylation marker in head and neck carcinomas. Oncogene. 2006; 25(36), 50185026.CrossRefGoogle ScholarPubMed
Hu, Z, Xie, L. LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway. Mol Med Rep. 2015; 12(3), 46344639.CrossRefGoogle ScholarPubMed
Liu, W, Jiang, X, Han, F, et al. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer. Cell Death Dis. 2013; 4(10), e882e882.CrossRefGoogle ScholarPubMed
Jung, S, Jeong, D, Kim, J, et al. Epigenetic regulation of the potential tumor suppressor gene, hLHX6. 1, in human cervical cancer. Int J Oncol. 2011; 38(3), 859869.Google ScholarPubMed
Yang, J, Han, F, Liu, W, et al. LHX6, an independent prognostic factor, inhibits lung adenocarcinoma progression through transcriptional silencing of β-catenin. J Cancer. 2017; 8(13), 25612574.CrossRefGoogle ScholarPubMed
Chen, H, Zhao, J, Li, Y, et al. Epigenetic inactivation of LHX6 mediated microcystin-LR induced hepatocarcinogenesis via the Wnt/β-catenin and P53 signaling pathways. Environ Pollut. 2019; 252(1), 216226.CrossRefGoogle ScholarPubMed
Bi, QJ, Men, XJ, Han, R, Li, GL. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/AKT/mTOR signaling pathway. Eur Rev Med Pharmacol Sci. 2018; 22(10), 30673073.Google ScholarPubMed
Nathalia, E, Theardy, MS, Elvira, S, et al. Downregulation of tumor-suppressor gene LHX6 in cancer: a systematic review. Rom J Intern Med. 2018; 56(3), 135142.Google ScholarPubMed
Garg, P, Jadhav, B, Rodriguez, OL, et al. A survey of rare epigenetic variation in 23,116 human genomes identifies disease-relevant epivariations and CGG expansions. Am J Hum Genet. 2020; 107(4), 654669.CrossRefGoogle ScholarPubMed
Supplementary material: File

Dangoni et al. supplementary material

Table S3

Download Dangoni et al. supplementary material(File)
File 12.2 KB
Supplementary material: File

Dangoni et al. supplementary material

Table S2

Download Dangoni et al. supplementary material(File)
File 96.1 KB
Supplementary material: File

Dangoni et al. supplementary material

Table S1

Download Dangoni et al. supplementary material(File)
File 12.3 KB